| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Alterations in comprehensive geriatric assessment decrease survival of elderly patients with cancer
|
Frasca, M.
|
|
2018
|
90 |
C |
p. 10-18
|
article
|
| 2 |
A randomised phase II trial of docetaxel versus docetaxel plus carboplatin in patients with castration-resistant prostate cancer who have progressed after response to prior docetaxel chemotherapy: The RECARDO trial
|
Bouman-Wammes, Esther W.
|
|
2018
|
90 |
C |
p. 1-9
|
article
|
| 3 |
Circulating oncometabolite D-2-hydroxyglutarate enantiomer is a surrogate marker of isocitrate dehydrogenase–mutated intrahepatic cholangiocarcinomas
|
Delahousse, Julia
|
|
2018
|
90 |
C |
p. 83-91
|
article
|
| 4 |
Complete response of a metastatic porocarcinoma treated with paclitaxel, cetuximab and radiotherapy
|
Godillot, C.
|
|
2018
|
90 |
C |
p. 142-145
|
article
|
| 5 |
Corrigendum to “A European randomised controlled trial of the addition of etoposide to standard vincristine and carboplatin induction as part of an 18-month treatment programme for childhood (≤16 years) low grade glioma – A final report” [Eur J of Canc (2017) 206–225]
|
Gnekow, Astrid K.
|
|
2018
|
90 |
C |
p. 156-157
|
article
|
| 6 |
C-statistic: A brief explanation of its construction, interpretation and limitations
|
Caetano, S.J.
|
|
2018
|
90 |
C |
p. 130-132
|
article
|
| 7 |
Histopathological regression predicts treatment outcome in locally advanced esophagogastric adenocarcinoma
|
Spoerl, Silvia
|
|
2018
|
90 |
C |
p. 26-33
|
article
|
| 8 |
Mammography screening: A major issue in medicine
|
Autier, Philippe
|
|
2018
|
90 |
C |
p. 34-62
|
article
|
| 9 |
Metastatic cutaneous apocrine adenocarcinoma responsive to the programmed cell death protein 1 inhibitor pembrolizumab
|
Rogatsch, Max
|
|
2018
|
90 |
C |
p. 146-148
|
article
|
| 10 |
3-Methoxytyramine: An independent prognostic biomarker that associates with high-risk disease and poor clinical outcome in neuroblastoma patients
|
Verly, I.R.N.
|
|
2018
|
90 |
C |
p. 102-110
|
article
|
| 11 |
Optimal adjuvant endocrine treatment of ER+/HER2+ breast cancer patients by age at diagnosis: A population-based cohort study
|
Dackus, G.M.H.E.
|
|
2018
|
90 |
C |
p. 92-101
|
article
|
| 12 |
Outcomes in women with invasive ductal or invasive lobular early stage breast cancer treated with anastrozole or exemestane in CCTG (NCIC CTG) MA.27
|
Strasser-Weippl, K.
|
|
2018
|
90 |
C |
p. 19-25
|
article
|
| 13 |
Overall survival in MERiDiAN, a double-blind placebo-controlled randomised phase III trial evaluating first-line bevacizumab plus paclitaxel for HER2-negative metastatic breast cancer
|
Miles, David
|
|
2018
|
90 |
C |
p. 153-155
|
article
|
| 14 |
Phase II trial of ipilimumab in melanoma patients with preexisting humoural immune response to NY-ESO-1
|
Haag, G.M.
|
|
2018
|
90 |
C |
p. 122-129
|
article
|
| 15 |
Positron emission tomography/computed tomography evaluation of oncolytic virus therapy efficacy in melanoma
|
Franke, Viola
|
|
2018
|
90 |
C |
p. 149-152
|
article
|
| 16 |
Red and processed meat consumption and breast cancer: UK Biobank cohort study and meta-analysis
|
Anderson, Jana J.
|
|
2018
|
90 |
C |
p. 73-82
|
article
|
| 17 |
The Danish Head and Neck Cancer fast-track program: a tertiary cancer centre experience
|
Roennegaard, Anders B.
|
|
2018
|
90 |
C |
p. 133-139
|
article
|
| 18 |
The subgroups of the phase III RECOURSE trial of trifluridine/tipiracil (TAS-102) versus placebo with best supportive care in patients with metastatic colorectal cancer
|
Van Cutsem, Eric
|
|
2018
|
90 |
C |
p. 63-72
|
article
|
| 19 |
Tumour endothelial marker 1/endosialin-mediated targeting of human sarcoma
|
Guo, Y.
|
|
2018
|
90 |
C |
p. 111-121
|
article
|
| 20 |
When politicians really decide that nation health is a top priority: the Danish model
|
Hamoir, Marc
|
|
2018
|
90 |
C |
p. 140-141
|
article
|
Journal description